Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4177G | ISIN: US71678J3086 | Ticker-Symbol:
NASDAQ
21.05.25 | 22:00
0,066 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PETROS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
PETROS PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur PETROS PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiPetros Pharmaceuticals will Tochtergesellschaft ausgliedern, um Finanzen zu verbessern3
Mi Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position201NEW YORK, NY / ACCESS Newswire / June 25, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the...
► Artikel lesen
20.06.Petros Pharmaceuticals, Inc. - 8-K, Current Report2
21.05.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets205The Company Intends to Appeal the Delisting Determination NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on...
► Artikel lesen
PETROS PHARMACEUTICALS Aktie jetzt für 0€ handeln
21.05.Petros Pharmaceuticals, Inc. - 8-K, Current Report2
20.05.Petros Pharmaceuticals partners with Innolitics for SaaS platform7
20.05.Petros Pharmaceuticals partners with Innolitics to accelerate SaaS platform development3
20.05.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer506With more than $10m in cash, and a significantly reduced burn rate, the Company is positioned to fully fund the development of its technology platform. NEW YORK, NY / ACCESS Newswire / May 20, 2025...
► Artikel lesen
15.05.Petros Pharmaceuticals, Inc. - 10-Q, Quarterly Report4
06.05.Petros Pharmaceuticals verbessert KI für Rx-to-OTC-Wechselplattform13
06.05.Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform2
06.05.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform234Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Petros...
► Artikel lesen
02.05.Petros Pharmaceuticals, Inc. - 8-K, Current Report1
01.05.Petros Pharmaceuticals schwenkt auf intelligente Gesundheitstechnologie um5
01.05.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches331Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again...
► Artikel lesen
29.04.Petros Pharmaceuticals gears up for Rx-to-OTC switch platform7
29.04.Petros Pharmaceuticals, Inc.: Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms365Company's AI and Big Data technology positioned to drive strong industry collaborationCompany also announces certain corporate actions NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Petros Pharmaceuticals...
► Artikel lesen
09.04.Petros Pharmaceuticals, Inc. - 8-K, Current Report1
20.03.Petros Pharmaceuticals enhances Rx-to-OTC switch technology7
20.03.Petros Pharmaceuticals verbessert Rx-to-OTC-Umstellungstechnologie4
Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1